{
    "root": "f492c348-c7b8-4004-847c-c023a10fbe47",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Loxapine",
    "value": "20250309",
    "ingredients": [
        {
            "name": "LOXAPINE SUCCINATE",
            "code": "X59SG0MRYU"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "BUTYLPARABEN",
            "code": "3QPI1U3FV8"
        },
        {
            "name": "EDETATE CALCIUM DISODIUM",
            "code": "25IH6R4SGF"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "POLACRILIN POTASSIUM",
            "code": "0BZ5A00FQU"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM PROPIONATE",
            "code": "DK6Y9P42IN"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FERROSOFERRIC PHOSPHATE",
            "code": "91GQH8I5F7"
        }
    ],
    "indications": "Loxapine capsules are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.",
    "contraindications": "Loxapine capsules are administered, usually in divided doses, two to four times a day. Daily dosage (in terms of base equivalents) should be adjusted to the individual patient’s needs as assessed by the severity of symptoms and previous history of response to antipsychotic drugs.",
    "warningsAndPrecautions": "Loxapine capsules, USP are available in the following strengths:\n                  Loxapine succinate, USP 6.8 mg equivalent to 5 mg loxapine, black ink, hard shell, opaque, with a white body and cap, printed with “Watson 369” on one half and “5 mg” on the other, are supplied in bottles of 100 (NDC 0591-0369-01).\n                  Loxapine succinate, USP 13.6 mg equivalent to 10 mg loxapine, black ink, hard shell, opaque, with a white body and yellow cap, printed with  “Watson 370” on one half and  “10 mg” on the other, are supplied in bottles of 100 (NDC 0591-0370-01).\n                  Loxapine succinate, USP 34.0 mg equivalent to 25 mg loxapine, black ink, hard shell, opaque, with a white body and green cap, printed with “Watson 371” on one half and “25 mg” on the other, are supplied in bottles of 100 (NDC 0591-0371-01).\n                  Loxapine succinate, USP 68.1 mg equivalent to 50 mg loxapine, black ink, hard shell, opaque, with a white body and blue cap, printed with “Watson 372” on one half and “50 mg” on the other, are supplied in bottles of 100 (NDC 0591-0372-01).\n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, child-resistant container.\n                  Manufactured In India By:\n                     Watson Pharma Private Limited\n                     \nVerna, Salcette Goa 403 722 INDIA\n                  Manufactured For:\n                     Teva Pharmaceuticals\n                     \nParsippany, NJ 07054\n                  Rev. B 3/2025",
    "adverseReactions": "Loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.).\n                  Loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines."
}